All In Biotech

Drug Trial Radar · NCT05747430

SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

Randomized, Controlled, Double-Masked Study to Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Epitheliopathy

Last checked: Nov 19, 2026Latest source record: Apr 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 155 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

155

Actual

Start

Feb 22, 2023

Primary completion

Mar 6, 2025

Study completion Mar 31, 2026

Sponsor

Lead sponsor
iRenix Medical, Inc.Industry
Sponsor type
Industry
First posted
Feb 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a randomized, double-masked study to evaluate the tolerability and safety of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 15 centers in the United States (US).

Conditions

  • Retinal Disease

Interventions

  • IRX-101Drug

    IRX-101 is a novel ocular anti-septic

  • Providone-IodineDrug

    5% Providone-Iodine

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of new drugTime frame: 1-hour and 1-week post-treatment

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Coastal Eye Surgeons, LLC

    Greenwich, Connecticut

  • Mississippi Retina Associates

    Madison, Mississippi

  • Erie Retina Research, LLC

    Erie, Pennsylvania

  • Charleston Neuroscience Institute

    Ladson, South Carolina

  • Retina Consultants of Texas

    Katy, Texas

  • Edward Wood, MD

    Round Rock, Texas

  • Retina Associates of Utah

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.